Dr. Dennis F. Moore
Claim this profileAscension Via Christi Hospitals Wichita
Studies Lung Cancer
Studies Breast Cancer
30 reported clinical trials
80 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage II
Stage III
2Breast Cancer
HER2 positive
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Dennis F. Moore is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
More about Dennis F. Moore
Clinical Trial Related4 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 15 Active Clinical TrialsTreatments Dennis F. Moore has experience with
- Radiation Therapy
- Atezolizumab
- Pembrolizumab
- Carboplatin
- Stereotactic Body Radiation Therapy
- Biospecimen Collection
Breakdown of trials Dennis F. Moore has run
Lung Cancer
Breast Cancer
Non-Small Cell Lung Cancer
Prostate Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dennis F. Moore specialize in?
Dennis F. Moore focuses on Lung Cancer and Breast Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage II.
Is Dennis F. Moore currently recruiting for clinical trials?
Yes, Dennis F. Moore is currently recruiting for 15 clinical trials in Wichita Kansas. If you're interested in participating, you should apply.
Are there any treatments that Dennis F. Moore has studied deeply?
Yes, Dennis F. Moore has studied treatments such as Radiation Therapy, Atezolizumab, Pembrolizumab.
What is the best way to schedule an appointment with Dennis F. Moore?
Apply for one of the trials that Dennis F. Moore is conducting.
What is the office address of Dennis F. Moore?
The office of Dennis F. Moore is located at: Ascension Via Christi Hospitals Wichita, Wichita, Kansas 67214 United States. This is the address for their practice at the Ascension Via Christi Hospitals Wichita.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.